HPV pill trial aims to clear precancerous cells without surgery
NCT ID NCT06979180
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study tests a supplement called Papillex® to see if it can help reverse abnormal cervical cells caused by HPV. Researchers will compare Papillex® to a placebo in 60 women with mild to moderate cervical changes (CIN 1 or 2). Participants take the supplement daily for 180 days and have follow-up Pap smears and HPV tests to check for improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CELLS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
KGK Science Inc.
RECRUITINGLondon, Ontario, N5Y 5V6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could Self-Sampling revolutionize cervical cancer screening?
- Texting parents could be key to curbing HPV-Related cancers
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- Simple blood test could spot returning throat cancer sooner
- Double probe heat therapy may slash cervical cancer risk in HIV-positive women